Quantcast

Latest Attention-deficit hyperactivity disorder management Stories

2010-10-04 07:00:00

FLORHAM PARK, N.J., Oct. 4 /PRNewswire/ -- Shionogi Inc., the U.S.-based group company of Shionogi & Co., Ltd., today announced the U.S. Food and Drug Administration approval of the non-stimulant medication KAPVAY(TM) (clonidine hydrochloride) extended-release tablets, an extended-release oral formulation for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents ages 6-17 years. KAPVAY(TM) is the only formulation of clonidine hydrochloride approved...

2010-09-16 07:30:00

Briefing hosted by Shire, the Entertainment Industries Council and the Lab School of Washington with actress Roxy Olin delivering keynote on behalf of Entertainment Industries Council as part of its mental health advocacy tour WASHINGTON, Sept. 16 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, has partnered with the Entertainment Industries Council (EIC) , the Lab School of Washington and other organizations in support of...

2010-09-14 12:35:16

Trial led by St. Jude Children's Research Hospital investigators finds medication restores sustained attention of many young survivors; work begins on new strategies to help survivors cope with this common challenge A medicine widely used to treat attention-deficit/hyperactivity disorder (ADHD) also provides long-term relief from the attention and behavior changes that affect many childhood cancer survivors, according to a multicenter trial led by St. Jude Children's Research Hospital...

2010-08-27 08:14:07

(Ivanhoe Newswire) -- Adults with attention-deficit/hyperactive disorder (ADHD) are showing greater improvement when receiving individual sessions of cognitive behavioral therapy (CBT) in addition to their monthly medication. "Approximately 4.4 percent of adults in the United States with ADHD, which is a disorder characterized by impairing levels of inattention, hyperactivity, and impulsivity. Medications have been the primary treatment; however, many adults with ADHD cannot or will not take...

2010-08-25 01:56:13

Adults with attention-deficit/hyperactivity disorder (ADHD) who received medication and individual sessions of cognitive behavioral therapy (CBT) showed greater improvement in symptoms through 12 months compared to patients who did not receive CBT, according to a study in the August 25 issue of JAMA. "Approximately 4.4 percent of adults in the United States have ADHD, which is a disorder characterized by impairing levels of inattention, hyperactivity, and impulsivity. Medications have been...

2010-08-25 01:52:29

Skills-based treatment added to medication helps patients handle persistent symptoms Adding cognitive behavioral therapy "“ an approach that teaches skills for handling life challenges and revising negative thought patterns "“ to pharmaceutical treatment for attention-deficit hyperactivity disorder (ADHD) significantly improved symptom control in a study of adult patients. The report from Massachusetts General Hospital (MGH) researchers appear in the August 25 Journal of the...

2010-08-23 07:05:00

NEW YORK, Aug. 23 /PRNewswire/ -- A new ADD/ADHD study found that a multi-modal hemispheric based program significantly improved the participant's educational outcomes. The study, "The Effect of Hemispheric Specific Remediation Strategies on the Academic Performance Outcome of Children With ADD/ADHD," was conducted by a research team including, Gerry Leisman, Robert Melillo, Sharon Thum, Mark Ransom, Michael Orlando, Christopher Tice, and Frederick Carrick. The study appears in the current...

2010-08-18 10:00:00

Rising rates of attention deficit hyperactivity disorder (ADHD) and large differences in diagnosis rates have led to fears that the condition is often being misdiagnosed. A new study from North Carolina State University demonstrates that these concerns are justified. The researchers found large discrepancies in diagnosis and treatment rates based on small differences in children's dates of birth. "The question we asked was whether children who are relatively young compared to their classroom...

2010-08-10 14:50:00

DUBLIN, August 10, 2010 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced the divestiture of Daytrana(R) (methylphenidate transdermal system) to Noven Pharmaceuticals, Inc. Daytrana, which is approved and marketed in the US for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents, will continue to be available for patients through Noven. Shire's divestiture agreement grants...

2010-07-29 15:30:59

A new study from Perth's Telethon Institute for Child Health Research shows an association between ADHD and a 'Western-style' diet in adolescents. The research findings have just been published online in the international Journal of Attention Disorders. Leader of Nutrition studies at the Institute, Associate Professor Wendy Oddy, said the study examined the dietary patterns of 1800 adolescents from the long-term Raine Study and classified diets into 'Healthy' or 'Western' patterns. "We found...


Word of the Day
call-note
  • The call or cry of a bird or other animal to its mate or its young.
'Call-note' is newer than 'bird-call,' which originally referred to 'an instrument for imitating the note of birds' but now also refers to 'the song or cry of a bird.'
Related